California Law Enhances Access to Donor Milk for Infants
California Expands Access to Donor Human Milk
Prolacta Bioscience, a leader in providing human milk-based nutritional products for critically ill and premature infants, welcomes the California State Legislature's recent enactment of a pivotal law aimed at increasing access to donor human milk resources. This legislative step signifies a monumental change for fragile infants who rely on this essential nutrition for better health outcomes.
Importance of Donor Human Milk
Health advocates recognize the critical role that donor human milk plays in enhancing health outcomes for vulnerable infants. Especially in neonatal intensive care units (NICUs), donor milk is known to significantly lower the risk of serious health issues. For instance, studies indicate that premature infants given donor milk experience a reduced incidence of necrotizing enterocolitis (NEC), a potentially fatal intestinal disease.
Legislative Impact on Health Equity
The new law expands coverage options for all licensed milk banks compliant with health and safety regulations, promoting health equity in communities. By ensuring donor milk is more widely available, California aims to improve health outcomes for fragile infants across various socio-economic backgrounds.
Statements from Prolacta Leadership
Prolacta's CEO, Scott Elster, expressed optimism regarding this legislative achievement, highlighting the victory it represents for vulnerable infants. He emphasized, "With the governor's signature, NICUs will have increased donor human milk resources, which are crucial during the first days of life for fragile infants. We appreciate the advocacy of Assemblywoman Weber and Senators Richard Roth and Susan Rubio for their dedication to this cause."
Prolacta's Commitment to Quality
Prolacta is committed to maintaining rigorous quality and safety standards in its operations. The company utilizes a donor milk screening process that meets the highest industry standards, mirroring stringent protocols similar to those found in blood plasma processing. This ensures that the human milk provided is of the utmost quality for babies who need it most.
About Prolacta Bioscience
Prolacta Bioscience is dedicated to advancing the science of human milk to improve health outcomes for critically ill and premature infants. Their products, based on human milk, are validated through over 30 peer-reviewed clinical studies. Serving the global community, Prolacta has positively impacted the lives of more than 100,000 extremely premature infants, ensuring they receive the nutrition necessary for their survival and growth.
Media Contact Information
If you're looking for insights or additional information about Prolacta Bioscience and their initiatives, you can reach out to Loren Kosmont, who serves as a media contact. Prolacta remains committed to transparency and communication.
Frequently Asked Questions
What is the significance of the new California law for donor milk access?
The law facilitates broader coverage for licensed milk banks, enhancing access to donor human milk for fragile infants across the state.
How does donor human milk benefit infants?
Donor human milk has been shown to reduce the risk of serious conditions like necrotizing enterocolitis, particularly in premature infants, improving their health outcomes considerably.
Who is Prolacta Bioscience?
Prolacta Bioscience is a life sciences company dedicated to developing human milk-based products that help critically ill and premature infants thrive.
What makes Prolacta's products unique?
Prolacta's products are developed under strict safety and quality standards, validated through extensive clinical studies, ensuring top-notch nutrition for infants.
How can I learn more about Prolacta?
For more information about Prolacta Bioscience and their offerings, visit their official website or reach out through their media contact.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.